chemoimmunotherapy love

chemoimmunotherapy

Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun medicine Any combination of chemotherapy and immunotherapy

Etymologies

from Wiktionary, Creative Commons Attribution/Share-Alike License

chemo- +‎ immunotherapy

Support

Help support Wordnik (and make this page ad-free) by adopting the word chemoimmunotherapy.

Examples

  • I like the theory that selenium uptake by cancer cells might make them more sensitive to chemoimmunotherapy.

    The New Super-Nutrition Ph.D. Richard A. Passwater 1991

  • On August 17, 1979 Dr. Donaldson reported a patient with carcinoma in the mouth who had elected to go with chemoimmunotherapy plus selenium yeast sixteen months earlier.

    The New Super-Nutrition Ph.D. Richard A. Passwater 1991

  • He has been receiving chemoimmunotherapy and selenium for five months.

    The New Super-Nutrition Ph.D. Richard A. Passwater 1991

  • I like the theory that selenium uptake by cancer cells might make them more sensitive to chemoimmunotherapy.

    The New Super-Nutrition Ph.D. Richard A. Passwater 1991

  • He has been receiving chemoimmunotherapy and selenium for five months.

    The New Super-Nutrition Ph.D. Richard A. Passwater 1991

  • On August 17, 1979 Dr. Donaldson reported a patient with carcinoma in the mouth who had elected to go with chemoimmunotherapy plus selenium yeast sixteen months earlier.

    The New Super-Nutrition Ph.D. Richard A. Passwater 1991

  • Three Phase I/II clinical trials are in progress: in pancreatic cancer combining IMP321 with gemcitabine in chemoimmunotherapy

    BioSpace.com Featured News and Stories 2010

  • The objective of chemoimmunotherapy is to amplify natural pre-existing T cell responses specific for any known or unknown tumor antigen and to recruit and amplify new tumor-specific

    BioSpace.com Featured News and Stories 2010

  • Ofatumumab was approved by the FDA on October 27, 2009 for patients with CLL, a slowly progressing cancer of the blood and bone marrow, whose cancer is no longer responding to other chemoimmunotherapy regimens.

    unknown title 2009

  • Ofatumumab was approved by the FDA on October 27, 2009 for patients with CLL, a slowly progressing cancer of the blood and bone marrow, whose cancer is no longer responding to other chemoimmunotherapy regimens.

    Media Newswire 2009

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.